Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

To screen, or not to screen (for dementia), that is still the question

A lead­ing group of med­ical experts on Tues­day declined to endorse cog­ni­tive screen­ing for old­er adults, fuel­ing a debate that has sim­mered for years.

The U.S. Pre­ven­tive Ser­vices Task Force said it could nei­ther rec­om­mend nor oppose cog­ni­tive screen­ing, cit­ing insuf­fi­cient sci­en­tif­ic evi­dence of the practice’s ben­e­fits and harms and call­ing for fur­ther stud­ies.

The task force’s work informs poli­cies set by Medicare and pri­vate insur­ers. Its rec­om­men­da­tions, an accom­pa­ny­ing sci­en­tif­ic state­ment and two edi­to­ri­als were pub­lished Tues­day in the Jour­nal of the Amer­i­can Med­ical Asso­ci­a­tion.

The task force’s new posi­tion comes as con­cern mounts over a ris­ing tide of old­er adults with Alzheimer’s dis­ease and oth­er demen­tias and treat­ments remain elu­sive. Near­ly 6 mil­lion Amer­i­cans have Alzheimer’s dis­ease; that pop­u­la­tion is expect­ed to swell to near­ly 14 mil­lion by 2050.

Because seniors are at high­er risk of cog­ni­tive impair­ment, pro­po­nents say screen­ing ? test­ing peo­ple with­out any symp­toms — is an impor­tant strat­e­gy to iden­ti­fy peo­ple with unrec­og­nized dif­fi­cul­ties and poten­tial­ly lead to bet­ter care.

This can start a dis­cus­sion with your doc­tor: ‘You know, you’re hav­ing prob­lems with your cog­ni­tion, let’s fol­low this up,’” said Stephen Rao of Cleve­land Clinic’s Lou Ruvo Cen­ter for Brain Health.

Oppo­nents say the ben­e­fits of screen­ing are unproven and the poten­tial for harm is wor­ri­some. “Get­ting a pos­i­tive result can make some­one wary about their cog­ni­tion and mem­o­ry for the rest of their life,” said Ben­jamin Ben­sadon, an asso­ciate pro­fes­sor of geri­atric med­i­cine at the Uni­ver­si­ty of Flori­da Col­lege of Med­i­cine.

The task force’s stance is con­tro­ver­sial, giv­en how poor­ly the health care sys­tem serves seniors with mem­o­ry and think­ing prob­lems. Physi­cians rou­tine­ly over­look cog­ni­tive impair­ment and demen­tia in old­er patients, fail­ing to rec­og­nize these con­di­tions at least 50% of the time, accord­ing to sev­er­al stud­ies.

When the Alzheimer’s Asso­ci­a­tion sur­veyed 1,954 seniors in Decem­ber 2018, 82% said they thought it was impor­tant to have their think­ing or mem­o­ry checked. But only 16% said physi­cians reg­u­lar­ly checked their cog­ni­tion.

What’s more, Medicare poli­cies appear to affirm the val­ue of screen­ing. Since 2011, Medicare has required that physi­cians assess a patient’s cog­ni­tion dur­ing an annu­al well­ness vis­it. But only 19% of seniors took advan­tage of this vol­un­tary ben­e­fit in 2016, the most recent year for which data is avail­able.

Dr. Ronald Petersen, co-author of an edi­to­r­i­al accom­pa­ny­ing the rec­om­men­da­tions, cau­tioned that they shouldn’t dis­cour­age physi­cians from eval­u­at­ing old­er patients’ mem­o­ry and think­ing.

There is increased aware­ness, both on the part of patients and physi­cians, of the impor­tance of cog­ni­tive impair­ment,” said Petersen, direc­tor of the Mayo Clinic’s Alzheimer’s Dis­ease Research Cen­ter. “It would be a mis­take if physi­cians didn’t pay more atten­tion to cog­ni­tion and con­sid­er screen­ing on a case-by-case basis.”

Sim­i­lar­ly, seniors shouldn’t avoid address­ing wor­ri­some symp­toms.

If some­one has con­cerns or a fam­i­ly mem­ber has con­cerns about their mem­o­ry or cog­ni­tive abil­i­ties, they should cer­tain­ly dis­cuss that with their clin­i­cian,” said Dr. Dou­glas Owens, chair of the task force and a pro­fes­sor at Stan­ford Uni­ver­si­ty School of Med­i­cine.

In more than a dozen inter­views, experts teased out com­plex­i­ties sur­round­ing this top­ic. Here’s what they told me:

Screen­ing basics. Cog­ni­tive screen­ing involves admin­is­ter­ing short tests (usu­al­ly five min­utes or less) to peo­ple with­out any symp­toms of cog­ni­tive decline. It’s an effort to bring to light prob­lems with think­ing and mem­o­ry that oth­er­wise might escape atten­tion.

Depend­ing on the test, peo­ple may be asked to recall words, draw a clock face, name the date, spell a word back­ward, relate a recent news event or sort items into dif­fer­ent cat­e­gories, among oth­er tasks. Com­mon tests include the Mini-Cog, the Mem­o­ry Impair­ment Screen, the Gen­er­al Prac­ti­tion­er Assess­ment of Cog­ni­tion and the Mini-Men­tal Sta­tus Exam­i­na­tion.

The task force’s eval­u­a­tion focus­es on “uni­ver­sal screen­ing”: whether all adults age 65 and old­er with­out symp­toms should be giv­en tests to assess their cog­ni­tion. It found a lack of high-qual­i­ty sci­en­tif­ic evi­dence that this prac­tice would improve old­er adults’ qual­i­ty of life, ensure that they get bet­ter care or pos­i­tive­ly affect oth­er out­comes such as care­givers’ effi­ca­cy and well-being.

A dis­ap­point­ing study. High hopes had rest­ed on a study by researchers at Indi­ana Uni­ver­si­ty, pub­lished in Decem­ber. In that tri­al, 1,723 old­er adults were screened for cog­ni­tive impair­ment, while 1,693 were not.

A year lat­er, seniors in the screen­ing group were not more depressed or anx­ious — impor­tant evi­dence of the lack of harm from the assess­ment. But the study failed to find evi­dence that peo­ple screened had a bet­ter health-relat­ed qual­i­ty of life or low­er rates of hos­pi­tal­iza­tions or emer­gency depart­ment vis­its.

Two-thirds of seniors who test­ed pos­i­tive for cog­ni­tive impair­ment in her study declined to under­go fur­ther eval­u­a­tion. That’s con­sis­tent with find­ings from oth­er stud­ies, and it tes­ti­fies to “how many peo­ple are ter­ri­fied of demen­tia,” said Dr. Tim­o­thy Hold­en, an assis­tant pro­fes­sor at Wash­ing­ton Uni­ver­si­ty School of Med­i­cine in St. Louis.

What seems clear is that screen­ing in and of itself doesn’t yield ben­e­fits unless it’s accom­pa­nied by appro­pri­ate diag­nos­tic fol­low-up and care,” said Nicole Fowler, asso­ciate direc­tor of the Cen­ter for Aging Research at Indi­ana University’s Regen­strief Insti­tute.

Selec­tive screen­ing. “Selec­tive screen­ing” for cog­ni­tive impair­ment is an alter­na­tive to uni­ver­sal screen­ing and has gained sup­port.

In a state­ment pub­lished last fall, the Amer­i­can Acad­e­my of Neu­rol­o­gy rec­om­mend­ed that all patients 65 and old­er seen by neu­rol­o­gists get year­ly cog­ni­tive health assess­ments. Also, the Amer­i­can Dia­betes Asso­ci­a­tion  rec­om­mends that all adults with dia­betes age 65 and old­er be screened for cog­ni­tive impair­ment at an ini­tial vis­it and annu­al­ly there­after “as appro­pri­ate.” And the Amer­i­can Col­lege of Sur­geons now rec­om­mends screen­ing old­er adults for cog­ni­tive impair­ment before surgery.

Why test select groups? Many patients with dia­betes or neu­ro­log­i­cal con­di­tions have over­lap­ping cog­ni­tive symp­toms and “it’s impor­tant to know if a patient is hav­ing trou­ble remem­ber­ing what the doc­tor said,” said Dr. Nor­man Fos­ter, chair of the work­group that devel­oped the neu­rol­o­gy state­ment and a pro­fes­sor of neu­rol­o­gy at the Uni­ver­si­ty of Utah.

Physi­cians may need to alter treat­ment reg­i­mens for old­er adults with cog­ni­tive impair­ment or work more close­ly with fam­i­ly mem­bers. “If some­one needs to man­age their own care, it’s impor­tant to know if they can do that reli­ably,” Fos­ter said.

With surgery, old­er patients who have pre­ex­ist­ing cog­ni­tive impair­ments are at high­er risk of devel­op­ing delir­i­um, an acute, sud­den-onset brain dis­or­der. Iden­ti­fy­ing these patients can alert med­ical staff to this risk, which can be pre­vent­ed or mit­i­gat­ed with appro­pri­ate med­ical atten­tion.

Also, peo­ple who learn they have ear­ly-stage cog­ni­tive impair­ment can be con­nect­ed with com­mu­ni­ty resources and take steps to plan for their future, med­ical­ly and finan­cial­ly. The hope is that, one day, med­ical treat­ments will be able to halt or slow the pro­gres­sion of demen­tia. But treat­ments cur­rent­ly avail­able don’t ful­fill that promise.

Steps after screen­ing. Screen­ing shouldn’t be con­fused with diag­no­sis: All these short tests can do is sig­nal poten­tial prob­lems.

If results indi­cate rea­son for con­cern, a physi­cian should ask knowl­edge­able fam­i­ly mem­bers or friends what’s going on with an old­er patient. “Are they depressed? Hav­ing prob­lems tak­ing care of them­selves? Ask­ing the same ques­tion repeat­ed­ly?” said Dr. David Reuben, chief of geri­atrics at UCLA’s David Gef­fen School of Med­i­cine and direc­tor of UCLA’s Alzheimer’s and Demen­tia Care pro­gram.

A com­pre­hen­sive his­to­ry and phys­i­cal exam­i­na­tion should then be under­tak­en to rule out poten­tial reversible caus­es of cog­ni­tive dif­fi­cul­ties, impli­cat­ed in about 10% of cas­es. These include sleep apnea, depres­sion, hear­ing or vision loss, vit­a­min B12 or folic acid defi­cien­cies, alco­hol abuse and side effects from anti­cholin­er­gic drugs or oth­er med­ica­tions, among oth­er con­di­tions.

Once oth­er caus­es are ruled out, neu­ropsy­cho­log­i­cal tests can help estab­lish a diag­no­sis.

If I detect mild cog­ni­tive impair­ment, the first thing I’ll do is tell a patient I don’t have any drugs for that but I can help you com­pen­sate for deficits,” Reuben said. The good news, he said: A sub­stan­tial num­ber of patients with MCI ? about 50% — don’t devel­op demen­tia with­in five years of being diag­nosed.

The bot­tom line. “If you’re con­cerned about your mem­o­ry or think­ing, ask your physi­cian for an assess­ment,” said Dr. David Knop­man, a neu­rol­o­gist at the Mayo Clin­ic. If that test indi­cates rea­son for con­cern, make sure you get appro­pri­ate fol­low-up.

That’s eas­i­er said than done if you want to see a demen­tia spe­cial­ist, not­ed Dr. Soo Bor­son, a pro­fes­sor emeri­ta of psy­chi­a­try at the Uni­ver­si­ty of Wash­ing­ton. “Every­one I know who’s doing clin­i­cal demen­tia care says they have wait lists of four to six months,” she said.

With short­ages of geri­atric psy­chi­a­trists, geri­a­tri­cians, neu­ropsy­chol­o­gists and neu­rol­o­gists, there aren’t enough spe­cial­ists to han­dle demands that would arise if uni­ver­sal screen­ing for cog­ni­tive impair­ment were imple­ment­ed, Bor­son warned.

If you’re a fam­i­ly mem­ber of an old­er adult who’s resist­ing get­ting test­ed, “reach out pri­vate­ly to your pri­ma­ry care physi­cian and express your con­cerns,” said Hold­en of Wash­ing­ton Uni­ver­si­ty. “And let your doc­tor know if the per­son isn’t see­ing these changes or is resis­tant to talk about it.”

This hap­pens fre­quent­ly because peo­ple with cog­ni­tive impair­ments are often unaware of their prob­lems. “But there are ways that we, as physi­cians, can work around that,” Hold­en said. “If a physi­cian han­dles the sit­u­a­tion with sen­si­tiv­i­ty and takes things one step at a time, you can build trust and that can make things much eas­i­er.”

Kaiser Health News (KHN) is a nation­al health pol­i­cy news ser­vice. It is an edi­to­ri­al­ly inde­pen­dent pro­gram of the Hen­ry J. Kaiser Fam­i­ly Foun­da­tion, which is not affil­i­at­ed with Kaiser Per­ma­nente.

In the col­umn Nav­i­gat­ing Aging,” KHN con­tribut­ing colum­nist Judith Gra­ham focus­es on med­ical issues and advice asso­ci­at­ed with aging and end-of-life care, help­ing America’s 45 mil­lion seniors and their fam­i­lies nav­i­gate the health care sys­tem.

News in Context:

Leave a Reply...

Loading Facebook Comments ...

Leave a Reply

Categories: Cognitive Neuroscience, Health & Wellness

Tags: , , , , , , , , , , , , , , , , , ,

Search in our Archives

Follow us and Engage via…

twitter_logo_header
RSS Feed

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Watch All Recordings Now (40+ Speakers, 12+ Hours)